Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001209191-22-024198

Options or other derivatives

  • Director acquired 69,424 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Friedman Bart Director 2022-04-08 Grant or award · Stock Option (Right to Buy) +69,424 69,424 D
Loading xslF345X03/doc4.xml…